Paper39119697
Liposomes with Low Levels of Grafted Poly(ethylene glycol) Remain Susceptible to Destabilization by Anti-Poly(ethylene glycol) Antibodies.
Chen BM and 8 others. ACS Nano, 2024. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. Liposomes with Low Levels of Grafted Poly(ethylene glycol) Remain Susceptible to Destabilization by Anti-Poly(ethylene glycol) Antibodies. Papers, record 39119697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39119697
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Liposomes with Low Levels of Grafted Poly(ethylene glycol) Remain Susceptible to Destabilization by Anti-Poly(ethylene glycol) Antibodies.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Polyethylene Glycols | Major topic |
| Liposomes | Major topic |
| Doxorubicin | Major topic |
| Animals | |
| Rats | |
| Antibodies | |
| Complement Activation | |
| Phosphatidylethanolamines | |
| Drug Liberation |
Source PubMed
References68
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27369864 | Anti-PEG antibodies in the clinic: Current issues and beyond PEGylation. | J Control Release | 2016 | https://conductscience.org/library/papers/27369864 | PubMed |
| 2 | 4177022 | Fixation of C' and C'la by rabbit gamma-G- and gamma-M-antibodies with particulate and soluble antigens. | J Immunol | 1968 | https://conductscience.org/library/papers/4177022 | PubMed |
| 3 | 36641121 | Accelerated clearance by antibodies against methoxy PEG depends on pegylation architecture. | J Control Release | 2023 | https://conductscience.org/library/papers/36641121 | PubMed |
| 4 | 6609269 | Anaphylatoxin formation during hemodialysis: effects of different dialyzer membranes. | Kidney Int | 1983 | https://conductscience.org/library/papers/6609269 | PubMed |
| 5 | 24626930 | Complement is activated by IgG hexamers assembled at the cell surface. | Science | 2014 | https://conductscience.org/library/papers/24626930 | PubMed |
| 6 | 33444669 | Replacement of L-amino acid peptides with D-amino acid peptides mitigates anti-PEG antibody generation against polymer-peptide conjugates in mice. | J Control Release | 2021 | https://conductscience.org/library/papers/33444669 | PubMed |
| 7 | 30366815 | Association of immune response with efficacy and safety outcomes in adults with phenylketonuria administered pegvaliase in phase 3 clinical trials. | EBioMedicine | 2018 | https://conductscience.org/library/papers/30366815 | PubMed |
| 8 | 36549393 | Anti-PEG antibodies before and after a first dose of Comirnaty® (mRNA-LNP-based SARS-CoV-2 vaccine). | J Control Release | 2023 | https://conductscience.org/library/papers/36549393 | PubMed |
| 9 | 27522158 | Pre-existing anti-PEG antibodies are associated with severe immediate allergic reactions to pegnivacogin, a PEGylated aptamer. | J Allergy Clin Immunol | 2016 | https://conductscience.org/library/papers/27522158 | PubMed |
| 10 | 31348638 | Pseudo-anaphylaxis to Polyethylene Glycol (PEG)-Coated Liposomes: Roles of Anti-PEG IgM and Complement Activation in a Porcine Model of Human Infusion Reactions. | ACS Nano | 2019 | https://conductscience.org/library/papers/31348638 | PubMed |
| 11 | 10837758 | Lipid vesicles and membrane fusion. | Adv Drug Deliv Rev | 1999 | https://conductscience.org/library/papers/10837758 | PubMed |
| 12 | 20536171 | Sensitive quantification of PEGylated compounds by second-generation anti-poly(ethylene glycol) monoclonal antibodies. | Bioconjug Chem | 2010 | https://conductscience.org/library/papers/20536171 | PubMed |
| 13 | 15921973 | Effect of grafted PEG on liposome size and on compressibility and packing of lipid bilayer. | Chem Phys Lipids | 2005 | https://conductscience.org/library/papers/15921973 | PubMed |
| 14 | 30023837 | Cardinal Role of Intraliposome Doxorubicin-Sulfate Nanorod Crystal in Doxil Properties and Performance. | ACS Omega | 2018 | https://conductscience.org/library/papers/30023837 | PubMed |
| 15 | 12739982 | Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies. | Clin Pharmacokinet | 2003 | https://conductscience.org/library/papers/12739982 | PubMed |
| 16 | 15202568 | PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles. | Eur J Cell Biol | 2004 | https://conductscience.org/library/papers/15202568 | PubMed |
| 17 | 35758934 | Anti-PEG Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine. | ACS Nano | 2022 | https://conductscience.org/library/papers/35758934 | PubMed |
| 18 | 27726379 | Measurement of Pre-Existing IgG and IgM Antibodies against Polyethylene Glycol in Healthy Individuals. | Anal Chem | 2016 | https://conductscience.org/library/papers/27726379 | PubMed |
| 19 | 3518749 | The membrane attack complex of complement. | Annu Rev Immunol | 1986 | https://conductscience.org/library/papers/3518749 | PubMed |
| 20 | 34891120 | Impact of anti-PEG antibody affinity on accelerated blood clearance of pegylated epoetin beta in mice. | Biomed Pharmacother | 2022 | https://conductscience.org/library/papers/34891120 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42345324 | In-Depth Characterization of PEGylated Liposomes: Using AF4 and HPLC-CAD in Tandem as a Strategy for Composition Assessment and Postinsertion Optimization. | Anal Chem | 2026 | https://conductscience.org/library/papers/42345324 | PubMed |
| 41139912 | The Distribution of Complement Proteins in Soft and Hard Coronas Impacts Macrophage Uptake of Nanoparticles. | Adv Healthc Mater | 2026 | https://conductscience.org/library/papers/41139912 | PubMed |
| 41008206 | Current Status and Future Prospects on Nanodelivery Systems Targeting the Small Intestine for Absorption of Bioactive Substances. | Foods | 2025 | https://conductscience.org/library/papers/41008206 | PubMed |
| 40632862 | Enhanced immunocompatibility and hemocompatibility of nanomedicines across multiple species using complement pathway inhibitors. | Sci Adv | 2025 | https://conductscience.org/library/papers/40632862 | PubMed |
| 40264371 | PEGylation technology: addressing concerns, moving forward. | Drug Deliv | 2025 | https://conductscience.org/library/papers/40264371 | PubMed |
| 39852793 | Regulating Immune Responses Induced by PEGylated Messenger RNA-Lipid Nanoparticle Vaccine. | Vaccines (Basel) | 2024 | https://conductscience.org/library/papers/39852793 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39119697
GET https://conductscience.org/api/papers/v1/39119697/references?page=2